Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
1
users have commented on this narrative
39
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Waldencast
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expansion Into Ulta Beauty Stores Will Boost Future Success
Key Takeaways Strong growth in Milk Makeup and Obagi Medical, with store expansion and innovation driving increased future revenue and market share. Operational efficiencies and improved cash flow enhance financial flexibility, allowing for further sales and marketing investments, boosting top-line growth.
View narrative
US$3.98
FV
53.8% undervalued
intrinsic discount
14.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 14 hours ago
author updated this narrative
Aquestive Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Upcoming FDA Approval Will Enable Needle-Free Epinephrine Adoption
Key Takeaways The FDA review and potential success of Anaphylm could drive strong revenue growth and shift market preference toward needle-free drug delivery. Strategic investments in awareness, payer access, and product pipeline position the company for rapid adoption, diversified revenue, and improved margins.
View narrative
US$8.42
FV
51.2% undervalued
intrinsic discount
42.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
about 14 hours ago
author updated this narrative
Cerus
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Aging Population And Regulatory Approvals Will Open New Markets
Key Takeaways Growing demand for blood safety and regulatory momentum are driving increased adoption of INTERCEPT products, supporting sustainable revenue and market share expansion. Shifting to a recurring revenue model with product innovation and geographic expansion boosts sales predictability and potential for higher margins.
View narrative
US$4.67
FV
72.8% undervalued
intrinsic discount
12.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
about 14 hours ago
author updated this narrative
eHealth
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Growing US Senior Demand Will Fuel Digital Medicare Expansion
Key Takeaways Expansion of the senior market and digital adoption, combined with tech investments, boost growth potential, customer efficiency, and margin stability. Industry consolidation and favorable commission trends position eHealth to capture greater market share and drive future revenue and earnings gains.
View narrative
US$9.50
FV
63.9% undervalued
intrinsic discount
3.95%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 14 hours ago
author updated this narrative
Personalis
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Liquid Biopsy Advances And Medicare Decisions Will Reshape Precision Medicine
Key Takeaways Rapid clinical adoption and strategic partnerships, alongside operational improvements, position Personalis for significant growth in the precision medicine and oncology markets. Imminent Medicare reimbursement decisions and a strong financial foundation underpin future margin expansion and long-term profitability.
View narrative
US$7.06
FV
34.0% undervalued
intrinsic discount
25.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
about 14 hours ago
author updated this narrative
Nerdy
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Advanced AI Adoption Will Expand Education Horizons
Key Takeaways Advanced AI features and product innovation are driving customer retention, market expansion, and increased engagement, supporting sustained top-line growth and profitability. Growing institutional demand and operational automation are fueling higher-margin contracts, cost reduction, and gross margin improvement, strengthening revenue trajectory and earnings potential.
View narrative
US$2.04
FV
37.8% undervalued
intrinsic discount
14.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
about 14 hours ago
author updated this narrative
8x8
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Cloud And AI Integration Will Drive Enterprise Digital Transformation
Key Takeaways Growing demand for cloud-native, AI-powered communication platforms aligns with 8x8's strategy, supporting sustainable revenue growth and higher customer retention through evolving offerings. Streamlined operations, focus on enterprise and regulated markets, and international expansion drive margin improvement and position the company for long-term differentiation.
View narrative
US$2.30
FV
19.6% undervalued
intrinsic discount
0.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 14 hours ago
author updated this narrative
HomeToGo
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Digital Booking And AI Will Redefine Global Accommodations
Key Takeaways Growing digital payments and AI-driven efficiencies are enhancing margins, operational leverage, and user experience, fueling further revenue and EBITDA improvements. Expansion of direct property inventory and the B2B segment is solidifying exclusive supply, boosting high-margin recurring revenue, and strengthening the brand's global footprint.
View narrative
€4.10
FV
61.0% undervalued
intrinsic discount
31.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 13 hours ago
author updated this narrative
ITM Power
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
EU Renewable Hydrogen Demand Will Spur Electrolyzer Capacity Expansion
Key Takeaways EU hydrogen strategy could boost ITM's revenues due to increased demand for their technology as electrolyzer capacity expands. Operational improvements and strategic initiatives enhance margins, revenue growth, and competitiveness while preserving cash flow.
View narrative
UK£0.87
FV
15.6% undervalued
intrinsic discount
54.29%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
36
users have followed this narrative
about 14 hours ago
author updated this narrative
Value any company in seconds
Popular companies